SG Americas Securities »

Celldex Therapeutics shares owned by SG Americas Securities

Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by SG Americas Securities from 13F filings

Historical chart of SG Americas Securities investment in Celldex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Celldex Therapeutics held by SG Americas Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celldex Therapeutics by SG Americas Securities

Quarter filed Position value Share count Share price at filing
2024-09-30 $691k 20k 34.01
2024-06-30 $335k 9.0k 37.04
2024-03-31 $851k 20k 41.97
2023-12-31 $1.8M 46k 39.67
2023-09-30 $2.1M 78k 27.52
2023-06-30 $167k 4.9k 33.86
2023-03-31 $374k 10k 36.00
2022-12-31 $303k 6.8k 44.55
2022-09-30 $367k 13k 28.08
2022-06-30 $1.5M 56k 26.96
2022-03-31 $475k 14k 34.03
2021-12-31 $390k 10k 38.66
2021-09-30 $1.1M 20k 54.00
2020-12-31 $440k 25k 17.53